Skip to content

Acupuncture in Neonatal Abstinence Syndrome (NAS) Babies

Acupuncture Use in Infants Treated for Neonatal Abstinence Syndrome: a Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02062151
Acronym
AA NAS
Enrollment
21
Registered
2014-02-13
Start date
2014-02-28
Completion date
2015-10-31
Last updated
2019-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Abstinence Syndrome

Keywords

Acupuncture

Brief summary

This pilot study is intended to assess feasibility of auricular acupuncture in NAS infants who require pharmacologic therapy. We intend to evaluate acceptability of auricular acupuncture, infant tolerance, recruitment strategies, and methodological issues. We plan to also test and generate hypotheses in preparation to apply for funding a larger randomized controlled trial.

Detailed description

Objectives: Primary: To establish feasibility of a protocol for auricular acupuncture in infants suffering from NAS admitted to the NICU receiving pharmacologic therapy. Secondary: In infants suffering from NAS admitted to the Neonatal Intensive Care Unit (NICU) receiving pharmacologic therapy: 1. Determine parent and staff acceptability of auricular acupuncture 2. Determine infant tolerance to auricular acupuncture 3. Evaluate the effect of auricular acupuncture on individual items of the Modified Finnegan Neonatal Abstinence Severity score associated with sympathetic nervous system responses 4. Evaluate the effect of auricular acupuncture on time to return to birth weight

Interventions

OTHERAcupuncture

Acupuncture

Sponsors

University of South Florida
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 3 Months
Healthy volunteers
No

Inclusion criteria

1. Gestational age ≥37.0 wks assessed by the obstetrical team from dating of last menstrual period, ultrasound, or best obstetric estimate 2. Admitted to NICU with diagnosis of NAS requiring pharmacologic therapy 3. Parents give written consent within 72 hours of infant receiving first dose of methadone

Exclusion criteria

1. Helix or antihelix of ear is deformed and needle is unable to be placed 2. A suspected or confirmed genetic or metabolic syndrome 3. Custody retained by the Department of Children and Families 4. Any skin condition involving the ear(s) 5. Suspected or documented infection at the time of enrollment

Design outcomes

Primary

MeasureTime frame
Number of Participants With Skin Breakdown and / or Cellulitisup to 57 days
Percentage of Dislodged NeedlesWithin three days of placement

Countries

United States

Participant flow

Participants by arm

ArmCount
NAS Babies
Acupuncture for NAS Acupuncture: Acupuncture
20
Total20

Withdrawals & dropouts

PeriodReasonFG000
Overall Studyscreen failure1

Baseline characteristics

CharacteristicNAS Babies
Age, Categorical
<=18 years
20 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
duration of methadone treatment21 days
STANDARD_DEVIATION 14
duration of nicu admission26 days
STANDARD_DEVIATION 15
Region of Enrollment
United States
20 participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
1 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Number of Participants With Skin Breakdown and / or Cellulitis

Time frame: up to 57 days

ArmMeasureValue (NUMBER)
NAS BabiesNumber of Participants With Skin Breakdown and / or Cellulitis0 participants
Primary

Percentage of Dislodged Needles

Time frame: Within three days of placement

ArmMeasureValue (NUMBER)
NAS BabiesPercentage of Dislodged Needles2 percentage of needles

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026